Avita Medical (ASX: AVH) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Avita Medical Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Avita Medical (ASX: AVH)
Latest News
Share Gainers
Why Avita Medical, GenusPlus, Mesoblast, and Polynovo shares are storming higher
Healthcare Shares
Guess which ASX healthcare stock is jumping 7% on US FDA approval news
Small Cap Shares
3 exciting small cap ASX shares to buy in November
Small Cap Shares
These small cap ASX shares could rise 25% to 100%
Small Cap Shares
Buy these small cap ASX shares before interest rates fall
Share Gainers
Why Avita Medical, Car Group, Dicker Data, and JB Hi-Fi shares are soaring today
Earnings Results
Avita Medical share price spikes 10% as sales jump in Q2
Healthcare Shares
2 popular ASX healthcare shares making news on Thursday
Small Cap Shares
Want to buy ASX small-cap shares? The shot clock is running out
Small Cap Shares
These small cap ASX shares could rise 35% to 75%
Small Cap Shares
Analysts name 3 small cap ASX shares to buy for big returns
Small Cap Shares
Why these small cap ASX shares could rise 85%+
Frequently Asked Questions
-
No, AVITA Medical does not pay dividends at this time.
-
AVITA Medical Inc listed on the ASX on 24 June 2020.
-
Yes, as well as being listed on the ASX, AVITA Medical Inc is listed on the US Nasdaq where it trades under the ticker NASDAQ: RCEL.
AVH ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Avita Medical
AVITA Medical Inc (ASX: AVH) is a healthcare company specialising in regenerative medicine. It is best known for its RECELL system, a burn treatment device that creates 'spray-on skin' from a patient's own skin cells within 30 minutes, avoiding or reducing the need for skin grafts.
The product was originally invented and patented by Western Australian doctor and clinical professor Fiona Wood in 1993.
RECELL is approved for use in Australia, Europe, Canada, China, the Middle East, and Africa. It is also approved for treating adult patients in the US. As well as burns, AVITA Medical has evidence of RECELL's effectiveness for additional skin applications, such as treating chronic and traumatic wounds, scar revision, and vitiligo.
AVITA Medical Inc is domiciled and also listed on the US Nasdaq where it trades under the ticker NASDAQ: RCEL.